Aspira Women’s Health (AWH) announced that Nicole Sandford, CEO and Board member, will be departing the Company to focus on a family health matter. Aspira’s President Dr. Sandra Milligan will step into the role of interim CEO while a nationwide search of internal and external candidates is conducted. Ms. Sandford’s departure will be effective immediately. She will remain as a consultant to ensure a seamless transition.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AWH:
- Aspira Women’s completes first development milestone of ARPA-H award
- Aspira Women’s Health Reports Q3 2024 Growth and Strategic Advances
- Aspira Women’s Health reports Q3 revenue $2.3M, consensus $2.73M
- Aspira Women’s Health Inc. (AWH) Q3 Earnings Cheat Sheet
- Aspira Women’s Health expands collaboration with Bioreference